If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpyrean Regulatory News (EME)

Share Price Information for Empyrean (EME)

Share Price is delayed by 15 minutes
Get Live Data
0.07    0.01 (16.67%)
Bid:
0.065
Ask:
0.075
Spread: 0.01 (15.385%)
Market Cap: £4.00m
EME Live PriceLast checked at - London Stock Exchange

Intraday Empyrean Share Chart

Duyung PSC Update

30 Jan 2026 07:00

RNS Number : 0774R
Empyrean Energy PLC
30 January 2026
 

 

30 January 2026

This announcement contains inside information

 

Empyrean Energy PLC / Index: AIM / Epic: EME / Sector: Oil & Gas

 

Empyrean Energy PLC ('Empyrean' or 'the Company')

Duyung PSC Update

 

Empyrean Energy plc ("Empyrean" or the "Company"), the oil and gas exploration and development company with interests in Australia, Indonesia and the United States, is pleased to announce that it has signed a binding term sheet for a settlement agreement (the "Term Sheet") with Conrad Asia Energy Ltd (ASX: CRD) ("Conrad"), the operator of the Duyung PSC and Mako Gas Field in Indonesia ("Mako"), which has successfully and amicably resolved the outstanding cash call dispute between Empyrean, Conrad and Conrad's subsidiary, West Natuna Exploration Limited ("WNEL"). As part of this Term Sheet, Conrad has withdrawn its Notice of Election of Remedy and Forced Withdrawal (the "Notice").

 

This Term Sheet reflects a cooperative and solution-focused approach by both parties and provides Empyrean with a clear, funded pathway to retain economic exposure to the Mako Gas Field as well Duyung PSC without future direct cash call obligations.

 

Highlights

· Term Sheet executed between Empyrean and Conrad for Duyung PSC settlement and resolution of the Mako Gas Field cash call dispute;

· Conrad Withdrawal Notice withdrawn;

· Project finance secured to cover Empyrean future funding exposure through to development; and

· Pathway to first gas from Mako targeted for Q4 2027

 

Summary of Term Sheet entered into between Conrad and Empyrean

 

Empyrean Participating Interest (PI) in Duyung PSC

· Empyrean's 8.5% Participating Interest ("PI") in the Duyung PSC will be transferred to WNEL;

· Empyrean and Conrad will establish a Singapore-domiciled special purpose vehicle ("SPV") with shareholdings of 8.5% to Empyrean and 91.5% to Conrad (the "Subscription");

· Following Indonesian government approval of Empyrean's PI transfer and the transfer of a 75% participating interest in the Duyung PSC from WNEL to a majority farm-in partner ("Majority Farminee"), WNEL will retain a 25% participating interest in the Duyung PSC ("Majority PI Transfer"); and

· Following the Empyrean PI Transfer, the Subscription and the Majority PI Transfer, 100% of the shares in WNEL will be transferred to the SPV ("WNEL Share Transfer").

 

Outstanding Cash Call Settlement

· On completion of the transactions above, Empyrean will pay US$353,388.50 to Conrad, representing 50% of the disputed outstanding cash call amount;

· A further US$353,388.50 will be paid to Conrad from Empyrean's share of SPV dividends.

· Settlement of these two payments will represent full and final settlement of all past claims that WNEL and Conrad may have against Empyrean.

 

WNEL Farm-out Benefits

· On completion of the transactions, Empyrean will be entitled to 8.5% of each instalment of the consideration to be made to WNEL by the Majority Farminee.

 

Debt Restructuring

It is noted that further definitive documentation will be prepared with regard to the settlement agreement, including a shareholders' agreement between Empyrean and Conrad in respect of the control of the SPV and Conrad's wholly owned subsidiary, WNEL. It is also noted that the Term Sheet requires restructuring of the secured convertible note with Empyrean's lender (the "Lender"), with the Lender to be paid preferentially from WNEL dividends. The Lender has been supportive of the process to date and work is ongoing to finalise the revised terms, with further announcements to follow in due course.

 

Empyrean Interim CEO, Gaz Bisht, commented:

 

"This is an outstanding outcome for Empyrean and a pivotal step forward for the Company. We have retained our ongoing economic exposure to a high-quality gas development with a clear pathway to first gas targeted for the fourth quarter of 2027, while eliminating future direct cash call obligations associated with field development. It is particularly satisfying that Empyrean has been involved in the full lifecycle of the Mako Gas Field - from the successful exploration well drilled in 2017, through two appraisal wells, to finalising the Plan of Development.

 

I would like to thank our shareholders for their patience and continued support of the Board and management during what has been a challenging period, as well as the support of our Lender. We also sincerely appreciate Conrad's constructive and collaborative approach, and in particular the leadership of its CEO, Miltos Xynogalas, whose commercial pragmatism and willingness to engage were instrumental in resolving the dispute.

 

With this matter now concluded, the Board and management are confident in renewing our focus on building value through the addition of further low-risk, high-quality assets to Empyrean's portfolio."

 

For further information please visit www.empyreanenergy.com or contact the following:

 

Empyrean Energy plc

Tel: +61 (8) 6146 5325

Gaz Bisht

Cavendish Capital Markets Limited (Nominated Advisor and Broker)

Tel: +44 (0) 207 220 0500

Neil McDonald

Pearl Kellie

AlbR Capital Limited (Joint Broker)

Tel: +44 (0)20 7469 0930

Colin Rowbury

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGLGDBIGXDGLG
Date   Source Headline
6th Feb 20251:49 pmRNSHolding(s) in Company
5th Feb 20252:47 pmRNSHolding(s) in Company
30th Jan 20257:00 amRNS£675,000 Placing
28th Jan 20253:39 pmRNSHolding(s) in Company
28th Jan 20257:50 amRNSLand access agreement for Wilson River 1 secured
23rd Jan 20257:00 amRNSParticipation option in the Wilson River prospect
6th Jan 20257:00 amRNSHolding(s) in Company
18th Dec 20247:00 amRNSInterim Results
4th Dec 20247:00 amRNSHolding(s) in Company
2nd Dec 202412:14 pmRNSResults of General Meeting
13th Nov 20247:00 amRNSPosting of Circular
12th Nov 20249:00 amRNSChange of Registered Office Address
11th Nov 202410:15 amRNSResults of Retail Offer
6th Nov 20247:22 amRNSRetail Offer
6th Nov 20247:00 amRNSProposed Fundraise and Capital Reorganisation
28th Oct 202412:11 pmRNSResults of General Meeting
8th Oct 20249:19 amRNSHolding(s) in Company
2nd Oct 202411:05 amRNSPosting of Annual Report and Notice of GM
1st Oct 20247:00 amRNSFinal Results
30th Sep 202410:48 amRNSResult of AGM
19th Sep 20244:14 pmRNSHolding(s) in Company
4th Sep 20241:36 pmRNSPosting of Notice of Annual General Meeting
2nd Sep 20247:00 amRNSGas Sale Agreement Signed with Sembcorp
22nd Aug 20249:02 amRNSBoard Restructure
26th Jul 20248:30 amRNSIssue of Salary Sacrifice Shares
24th Jun 20247:00 amRNSMako Binding Gas Sale Agreement Signed with PGN
13th Jun 20247:00 amRNSBlock 29/11 China update
5th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 20247:57 amRNSMako Gas Sale Key Terms Signed with PGN
23rd Feb 20247:39 amRNSMinisterial Approval of Mako Gas Price
13th Feb 20247:00 amRNSEmpyrean completes £700,000 Placing
31st Jan 20247:00 amRNSDuyung PSC Update
18th Dec 202311:34 amRNSInterim Results
20th Nov 20232:40 pmRNSChange of Nominated Adviser
27th Sep 202312:58 pmRNSResult of AGM
15th Sep 20237:00 amRNSIssue of Salary Sacrifice Shares
12th Sep 20237:13 amRNSKey Terms Agreed for Long-Term Gas Sales Agreement
4th Sep 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Sep 202312:30 pmRNSFinal Results
30th May 20237:36 amRNSCapital raising, Debt Restructure & Company Update
2nd May 20237:00 amRNSMako gas field - Update
4th Jan 20234:40 pmRNSSecond Price Monitoring Extn
4th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20227:00 amRNSInterim Results
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
8th Nov 20227:00 amRNSMako Gas - Approval of Updated Plan of Development
19th Oct 20221:19 pmRNSResults of General Meeting
27th Sep 202212:54 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.